Reduced Cortical Excitability, Neuroplasticity, and Salivary Cortisol in 11–13-Year-Old Children Born to Women with Gestational Diabetes Mellitus
Jago M. Van Dam(The University of Adelaide), Julia B. Pitcher(The University of Adelaide), Janet Rowan(Auckland City Hospital), Mitchell R. Goldsworthy(The University of Adelaide), Nicolette A. Hodyl(The University of Adelaide), Suzette Coat(The University of Adelaide), William M. Hague(University of Adelaide), Luke A. Schneider(The University of Adelaide), Amy J. Garrett(The University of Adelaide)
Cited by 40
Related Papers
Metformin versus Insulin for the Treatment of Gestational Diabetes
|New England Journal of Medicine|2008|1.3k
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
|Diabetes Care|2011|385
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
|BMJ Open Diabetes Research & Care|2018|295
An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes
|Diabetes Care|2014|239
Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes
|Archives of Disease in Childhood Fetal & Neonatal|2016|109